Engineered pig cutaneous growth substance (rEGF) is receiving increased attention as a valuable strategy in the domain of tissue therapy. This biological compound, produced through genetic engineering, delivers a https://recombinantporcineegf134449.activoblog.com/369570/recombinant-swine-skin-development-substance-a-effective-agent-for-tissue-regeneration